Trial · NCT07885631
A School-Based Intervention to Prevent Disordered Eating in Middle School Students
NCT07885631, Not applicable, Completed, Izmir Katip Celebi University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A School-Based Intervention to Prevent Disordered Eating in Middle School Students. Trials, record NCT07885631. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885631
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A School-Based Intervention to Prevent Disordered Eating in Middle School Students
- NCT number
- NCT07885631
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 235 participants, actual
- Lead sponsor
- Izmir Katip Celebi University
- Conditions
- Disordered Eating Behaviors
- Interventions
- School-Based Disordered Eating Prevention Education Program
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Eating Attitudes Test-26 (EAT-26) Score | Baseline, immediately post-intervention (intervention group only), and 12-week follow-up | Eating attitudes were assessed using a 24-item version of the Eating Attitudes Test-26 (EAT-26). Total scores range from 0 to 72, with higher scores indicating a greater risk of disordered eating attitudes and behaviors. |
| Secondary | Change in Eating Disorder Examination Questionnaire Short Parent Version (EDE-QS-P) Score | Baseline, immediately post-intervention (intervention group only), and 12-week follow-up | Eating disorder symptoms in students were assessed from the parent perspective using the Eating Disorder Examination Questionnaire Short Parent Version (EDE-QS-P). Total scores range from 0 to 33, with higher scores indicating greater severity of eating disorder symptoms. |
| Secondary | Change in Body Satisfaction | Baseline, immediately post-intervention (intervention group only), and 12-week follow-up | Body satisfaction was assessed using a Numerical Rating Scale (NRS), on which students rated their level of satisfaction with their body. The minimum possible score is 0 ("not at all satisfied"), and the maximum possible score is 10 ("very satisfied"). Higher scores indicate greater body satisfaction. Changes in body satisfaction scores were evaluated across the assessment time points. |
| Secondary | Change in Sociocultural Attitudes | Baseline, immediately post-intervention (intervention group only), and 12-week follow-up | Sociocultural attitudes toward appearance were assessed using the Sociocultural Attitudes Towards Appearance Questionnaire-4 Revised (SATAQ-4R), which consists of 31 items across seven subscales assessing internalization of appearance ideals and perceived appearance-related pressures. Items are rated on a 5-point Likert scale. Possible subscale scores range from 4 to 20 for thinness/low body fat internalization and each perceived pressure subscale (family, peers, significant others, and media), from 5 to 25 for muscularity internalization, and from 6 to 30 for general attractiveness internalization. Higher subscale scores indicate greater internalization of sociocultural appearance ideals or greater perceived appearance-related pressure. |
| Secondary | Change in Social Media Literacy | Baseline, immediately post-intervention (intervention group only), and 12-week follow-up | Social media literacy was assessed using the Information Awareness dimension of the Social Media Literacy Scale (SMOÖ). This dimension evaluates students' awareness and critical understanding of information encountered on social media. The minimum possible score is 3, and the maximum possible score is 15. Higher scores indicate greater information awareness in relation to social media content. |
| Secondary | Change in BMI-for-Age Z-Score | Baseline and 12-week follow-up | BMI-for-age z-scores were calculated based on participants' measured body weight and height using age- and sex-specific reference standards. Changes in BMI-for-age z-scores were evaluated from baseline to the 12-week follow-up. |
| Secondary | Change in Waist Circumference | Baseline and 12-week follow-up | Waist circumference was measured in centimeters (cm) using a non-stretchable measuring tape. Changes in waist circumference were evaluated from baseline to the 12-week follow-up. |
| Secondary | Change in Body Fat Percentage | Baseline and 12-week follow-up | Body fat percentage was assessed using bioelectrical impedance analysis. Changes in body fat percentage were evaluated from baseline to the 12-week follow-up. |
| Secondary | Change in Diet Quality and Dietary Intake | Baseline and 12-week follow-up | Diet quality was assessed using the Mediterranean Diet Quality Index for Children and Adolescents (KIDMED). Total KIDMED scores range from -4 to 12, with higher scores indicating greater adherence to the Mediterranean diet. Dietary intake was assessed using dietary records to estimate energy and nutrient intakes. Changes in diet quality and dietary intake were evaluated from baseline to the 12-week follow-up. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885631
GET https://conductscience.org/api/trials/v1/NCT07885631/registered